Trials / Active Not Recruiting
Active Not RecruitingNCT06652620
Cola Ingestion for Esophageal Bolus Impaction
A Prospective, Randomized Controlled Study on Cola Ingestion for Bolus Impaction in Patients With Esophageal Cancer
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to observe whether cola ingestion can improve the 24-hour remission rate of acute esophageal impaction in patients with esophageal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cola | regular Coca-Cola (Coca-Cola company, Atlanta, GA) or Pesi-cola (PepsiCo, Inc.New York, NY) |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2026-02-01
- Completion
- 2026-12-31
- First posted
- 2024-10-22
- Last updated
- 2026-03-16
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06652620. Inclusion in this directory is not an endorsement.